Literature DB >> 27099319

Influenza Virus Hemagglutinin Glycoproteins with Different N-Glycan Patterns Activate Dendritic Cells In Vitro.

Wen-Chun Liu1, Yu-Li Lin2, Maureen Spearman3, Pei-Yun Cheng2, Michael Butler3, Suh-Chin Wu4,5.   

Abstract

UNLABELLED: Influenza virus hemagglutinin (HA) N-glycans play important regulatory roles in the control of virus virulence, antigenicity, receptor-binding specificity, and viral escape from the immune response. Considered essential for controlling innate and adaptive immune responses against influenza virus infections, dendritic cells (DCs) trigger proinflammatory and adaptive immune responses in hosts. In this study, we engineered Chinese hamster ovary (CHO) cell lines expressing recombinant HA from pandemic H1, H5, and H7 influenza viruses. rH1HA, rH5HA, and rH7HA were obtained as wild-type proteins or in the presence of kifunensine (KIF) or further with endo-β-N-acetylglucosaminidase-treated KIF (KIF+E) to generate single-N-acetylglucosamine (GlcNAc) N-glycans consisting of (i) terminally sialylated complex-type N-glycans, (ii) high-mannose-type N-glycans, and (iii) single-GlcNAc-type N-glycans. Our results show that high-mannose-type and single-GlcNAc-type N-glycans, but not complex-type N-glycans, are capable of inducing more active hIL12 p40, hIL12 p70, and hIL-10 production in human DCs. Significantly higher HLA-DR, CD40, CD83, and CD86 expression levels, as well reduced endocytotic capacity in human DCs, were noted in the high-mannose-type rH1HA and single-GlcNAc-type rH1HA groups than in the complex-type N-glycan rH1HA group. Our data indicate that native avian rHA proteins (H5N1 and H7N9) are more immunostimulatory than human rHA protein (pH1N1). The high-mannose-type or single-GlcNAc-type N-glycans of both avian and human HA types are more stimulatory than the complex-type N-glycans. HA-stimulated DC activation was accomplished partially through a mannose receptor(s). These results provide more understanding of the contribution of glycosylation of viral proteins to the immune responses and may have implications for vaccine development. IMPORTANCE: Influenza viruses trigger seasonal epidemics or pandemics with mild-to-severe consequences for human and poultry populations. DCs are the most potent professional antigen-presenting cells, which play a crucial role in the link between innate and adaptive immunity. In this study, we obtained stable-expression CHO cells to produce rH1HA, rH5HA, and rH7HA proteins containing distinct N-glycan patterns. These rHA proteins, each with a distinct N-glycan pattern, were used to investigate interactions with mouse and human DCs. Our data indicate that native avian rHA proteins (H5N1 and H7N9) are more immunostimulatory than human rHA protein (pH1N1). High-mannose-type and single-GlcNAc-type N-glycans were more effective than complex-type N-glycans in triggering mouse and human DC activation and maturation. We believe these results provide some useful information for influenza vaccine development regarding how influenza virus HA proteins with different types of N-glycans activate DCs.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27099319      PMCID: PMC4907228          DOI: 10.1128/JVI.00452-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

Review 1.  Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting.

Authors:  Paul J Tacken; I Jolanda M de Vries; Ruurd Torensma; Carl G Figdor
Journal:  Nat Rev Immunol       Date:  2007-10       Impact factor: 53.106

Review 2.  Inflammatory signals in dendritic cell activation and the induction of adaptive immunity.

Authors:  Olivier Joffre; Martijn A Nolte; Roman Spörri; Caetano Reis e Sousa
Journal:  Immunol Rev       Date:  2009-01       Impact factor: 12.988

Review 3.  DC subsets in positive and negative regulation of immunity.

Authors:  Caroline Coquerelle; Muriel Moser
Journal:  Immunol Rev       Date:  2010-03       Impact factor: 12.988

4.  Expression of multilectin receptors and comparative FITC-dextran uptake by human dendritic cells.

Authors:  M Kato; T K Neil; D B Fearnley; A D McLellan; S Vuckovic; D N Hart
Journal:  Int Immunol       Date:  2000-11       Impact factor: 4.823

5.  Involvement of the mannose receptor in infection of macrophages by influenza virus.

Authors:  P C Reading; J L Miller; E M Anders
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

6.  The ability of pandemic influenza virus hemagglutinins to induce lower respiratory pathology is associated with decreased surfactant protein D binding.

Authors:  Li Qi; John C Kash; Vivien G Dugan; Brett W Jagger; Yuk-Fai Lau; Zhong-Mei Sheng; Erika C Crouch; Kevan L Hartshorn; Jeffery K Taubenberger
Journal:  Virology       Date:  2011-02-18       Impact factor: 3.616

7.  Detailed structural analysis of N-glycans released from glycoproteins in SDS-PAGE gel bands using HPLC combined with exoglycosidase array digestions.

Authors:  Louise Royle; Catherine M Radcliffe; Raymond A Dwek; Pauline M Rudd
Journal:  Methods Mol Biol       Date:  2006

8.  Differential type I interferon induction by respiratory syncytial virus and influenza a virus in vivo.

Authors:  Nancy A Jewell; Negin Vaghefi; Sara E Mertz; Parvis Akter; R Stokes Peebles; Lauren O Bakaletz; Russell K Durbin; Emilio Flaño; Joan E Durbin
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

9.  Role of viral hemagglutinin glycosylation in anti-influenza activities of recombinant surfactant protein D.

Authors:  Kevan L Hartshorn; Richard Webby; Mitchell R White; Tesfaldet Tecle; Clark Pan; Susan Boucher; Rodney J Moreland; Erika C Crouch; Ronald K Scheule
Journal:  Respir Res       Date:  2008-09-23

10.  Protective influenza-specific CD8 T cell responses require interactions with dendritic cells in the lungs.

Authors:  Jodi McGill; Nico Van Rooijen; Kevin L Legge
Journal:  J Exp Med       Date:  2008-07-07       Impact factor: 14.307

View more
  10 in total

1.  Animal Cell Expression Systems.

Authors:  M Butler; U Reichl
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

2.  Impact of Protein Glycosylation on the Design of Viral Vaccines.

Authors:  Kathleen Schön; Bernd Lepenies; Guillaume Goyette-Desjardins
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

3.  Immune Responses Induced by Recombinant Bacillus Subtilis Expressing the Hemagglutinin Protein of H5N1 in chickens.

Authors:  Chunxiao Mou; Liqi Zhu; Jingjing Yang; Wenwen Xu; Xiaoying Cheng; Qian Yang
Journal:  Sci Rep       Date:  2016-12-16       Impact factor: 4.379

4.  A DNA Vaccine That Targets Hemagglutinin to Antigen-Presenting Cells Protects Mice against H7 Influenza.

Authors:  Tor Kristian Andersen; Fan Zhou; Rebecca Cox; Bjarne Bogen; Gunnveig Grødeland
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

5.  The Length of N-Glycans of Recombinant H5N1 Hemagglutinin Influences the Oligomerization and Immunogenicity of Vaccine Antigen.

Authors:  Agnieszka Katarzyna Macioła; Maria Anna Pietrzak; Piotr Kosson; Mariusz Czarnocki-Cieciura; Krzysztof Śmietanka; Zenon Minta; Edyta Kopera
Journal:  Front Immunol       Date:  2017-04-20       Impact factor: 7.561

6.  Glycosylation of HIV Env Impacts IgG Subtype Responses to Vaccination.

Authors:  Rebecca Heß; Michael Storcksdieck Genannt Bonsmann; Dennis Lapuente; Andre Maaske; Carsten Kirschning; Jürgen Ruland; Bernd Lepenies; Drew Hannaman; Matthias Tenbusch; Klaus Überla
Journal:  Viruses       Date:  2019-02-13       Impact factor: 5.048

Review 7.  Orchestrated efforts on host network hijacking: Processes governing virus replication.

Authors:  Xiaofeng Dai; Olivier Hakizimana; Xuanhao Zhang; Aman Chandra Kaushik; Jianying Zhang
Journal:  Virulence       Date:  2020-12       Impact factor: 5.882

8.  Development and characterization of influenza M2 ectodomain and/or hemagglutinin stalk-based dendritic cell-targeting vaccines.

Authors:  Titus Abiola Olukitibi; Zhujun Ao; Hiva Azizi; Mona Mahmoudi; Kevin Coombs; Darwyn Kobasa; Gary Kobinger; Xiaojian Yao
Journal:  Front Microbiol       Date:  2022-08-08       Impact factor: 6.064

9.  Recombinant hemagglutinin produced from Chinese Hamster Ovary (CHO) stable cell clones and a PELC/CpG combination adjuvant for H7N9 subunit vaccine development.

Authors:  Ting-Hsuan Chen; Wen-Chun Liu; I-Chen Chen; Chia-Chyi Liu; Ming-Hsi Huang; Jia-Tsrong Jan; Suh-Chin Wu
Journal:  Vaccine       Date:  2019-08-02       Impact factor: 3.641

10.  Immune response in piglets orally immunized with recombinant Bacillus subtilis expressing the capsid protein of porcine circovirus type 2.

Authors:  Shuai Zhang; Chunxiao Mou; Yanan Cao; En Zhang; Qian Yang
Journal:  Cell Commun Signal       Date:  2020-02-11       Impact factor: 5.712

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.